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Abstract 
 
 Efforts in malaria treatment are currently directed towards the discovery and 
development of new antimalarial compounds. In this way two plants Cochlospermum 
tinctorium A. Rich. (Cochlospermaceae) and Gardenia sokotensis Hutch (Rubiaceae) 
traditionally used to treat symptoms of malaria in Burkina Faso were screened for antimalarial 
activity in vivo with Plasmodium berghei. Dichloromethane extract of Cochlospermum 
tinctorium and dichloromethane-methanol (7/3v/v) of Gardenia sokotensis showed a 
promising in vivo antiplasmodial activity with 50% effective dose of 17.59 mg/kg and 115 
mg/kg respectively. Water extracts from the two plants showed an interesting antiplasmodial 
activity of Cochlospermum tinctorium and a weak activity for Gardenia sokotensis. 
Paradoxically chromatographic fractions issued from the active crude extract of 
Cochlospermum tinctorium appear less active. The fraction FGs2 of Gardenia has showed a 
pronounced activity with 42% inhibition rate at 50 mg /kg. These results reflected in part the 
previous in vitro studies conducted on the two plants. Phytochemical screening revealed 
mostly the presence of triterpenes, carotenoids and flavonoids more or less in pure state. 
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Introduction 
 
            The treatment of malaria has become more and more difficult over the past three 
decades, with the appearance of resistant parasites and the increasing cost of effective 
antimalarial drugs. New drugs against the disease are greatly needed. 
 In Africa, as in many other parts of the tropical world the cost of western medicine 
and the weakness of health care infrastructure force the larger part of the population to use 
traditional plant medicine as the first choice for treatment of malaria and other diseases. This 
has consequently led to a traditional practice for treatment of disease with folk medicine to be 
preserved. Assuming that some of this might have an effect, folk medicine could be a source 
of new active principles and phytomedicines. 
           Cochlospermum tinctorium A. Rich (Cochlospermaceae) and Gardenia sokotensis 
Hutch (Rubiaceae) are two medicinal plants widely used in traditional medicine in malaria 
treatment in our country (Aké Assi and Guinko, 1991; Traoré, 1983). A series of bioguided 
fractionation conducted by us led to the identification of molecules from Cochlospermum 
tinctorium (Ballin et al., 2002). In contrast no pure fraction has been isolated from Gardenia 
sokotensis and the fractions of the plant showed a very moderate in vitro antiplasmodial 
activity. The decoctions of roots of Cochlospermum planchonii have been found to be 
effective for the treatment of uncomplicated Plamodium falciparum malaria without any 
major side effects (Benoit-Vical et al., 2003). According to the authors the decoctions of the 
two plants are indifferently used by traditional healers to treat fevers and malaria. 
Antiplasmodial efficacy of some natural products may be potentiated in vivo by other 
compounds which occur in the extracts and yet may need to be metabolized to the active 
form. Such compounds may be missed by assays using in vitro models. So the aim of this 
study is to identify the potential antiplasmodial compounds of these two plants in vivo. 
 
Material and methods 
Uses in traditional medicine 
 
Rhizomes of Cochlospermum tinctorium are used against fever, hepatitis (Ekanem, 1994), 
abdominal pain, helminth and bilharzia infestations. The rhizomes are also used as antifungal 
and antibacterial (Nikiani et al., 1990); have been found to have hepatoprotective effects 
(Diallo et al., 1992) and possess in vitro antimalarial activity (Benoit et al. 1995). 
Leaves of Gardenia sokotensis are indicated in the treatment of malaria (Dakuyo, 1992), 
fever, asthenia, gastro-enteritis, (Ake Assi and Guinko, 1991); few pharmacological studies 
have been conducted on the plant. 
 
Previously isolated class of constituent 
 
Rhizomes of Cochlospermum tinctorium: triacylbenzenes, triterpenes (arjunolic acid), 
apocarotenoids (cochloxanthine and dihydrocochloxanthine), flavonoids, Tannins 
(ellagitannins, gallic acid) (Diallo, 1991).- Leaves of Gardenia sokotensis: sterols and 
triterpenes, flavonoids, tannins, saponines (Traoré et al., 2000) 
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Plant materials and extraction 
 
 Cochlospermum tinctorium and Gardenia sokotensis have been candidates for in vivo 
antiplasmodial screening from a previous study on eight plants used by our traditional healers 
in the treatment of malaria. The two plant materials were respectively collected in the same 
sites as the traditional healers. Rhizomes of Cochlospermum tinctorium A Rich 
(Cochlospermaceae) were collected in the Banfora area of Burkina Faso and the leaves of 
Gardenia sokotensis Hutch (Rubiaceae) in the East part of the country. Voucher specimens of 
the two plants were collected and deposited in the Herbarium of CNRST (Centre National de 
la Recherche Scientifique et Technologique) respectively under accession numbers 8709 and 
8710. 
 
Petroleum ether extract (PE) 
 
            300g of plant material were soaked with 500ml of petroleum ether during 24 hours. 
The extract was percolated with 500 ml of petroleum ether and concentrated. 
 
Dichloromethane extract (CH2CL2) 
 
           The remaining plant material extracted by the first solvent was extracted a second time 
with 500ml of Dichloromethane, percolated again with 500 ml of the solvent. 
Dicloromethane-methanol extract (7/3) (CH2CL2/MeOH 7/3), Dicloromethane-methanol (3/7) 
(CH2CL2/MeOH 3/7), methanol (MeOH), and aqueous extracts (H2O) were successively 
extracted in the same way. 
 
Fractionation process  
 
          The extract with the most antiplasmodial activity from each plant was fractionated. 
Merck silicagel 60 (0.040-0.063 mm) was used for column chromatography and Merck 
silicagel 60F254 for Thin Layer Chromatography (TLC). Elution was started with 
dichloromethane followed by dichloromethane /methanol mixtures with increasing the 
proportion of methanol (2.5, 5, 10, 12,5, 15%). 10 ml portions of the eluate were collected 
and monitored by TLC. Same eluates were combined. 
 
Antiplasmodial test performed in mice 
 
           The test was run according to the four day suppressive test of Peters on mice weighing 
between 20-25g maintained in same conditions of temperature (22±3ºC), diet and light. Mice 
divided in groups (according to doses) of five mice received daily oral extracts dissolved in 
sterile water containing Tween 85 and DMSO. Mice were treated from day 0 and monitored 
for seven days. The control group received the standard solution of extract dilution. Quinine 
was used as positive control at the doses 10, 15, 20, 25, 50, 100, 200 mg/kg. On the last day 
of the test blood smears were made and stained with Field’s reagent; then the number of 
parasitized red blood cells was determined. The mean percentage of inhibition at each dose 
was calculated. The 6 first extracts of each plant were tested at the same dose (12.5 mg/kg for 
Cochlospermum and 500mg/kg for Gardenia) to identify the most active extract; and its 
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Table 1: Inhibitory effect of the two plant extracts on parasites 
 
   PE CH2Cl2 CH2Cl2/CH3OH
(7/3 v/v) 
CH2Cl2/CH3OH
(3/7 v/v) 
CH3OH H2O 
Ct    5.25 0.48 0.79 2.11 1.78 3.06Yield (%) 
Gs    
  
  
        
       
2.11 11.25 3.57 2.85 2.45 7.9
Ct (12.5mg/kg) 20±2.52a 60±2.52 35±4.16 45±5 44±4.35 46±9.24Mean reduction rate (%) 
Gs (500mg/kg) 27±5.51 72±2.08 87±8.54 26±9.71 48±8.50 17±2.52
Ct 17.59ED50 (mg/kg) 
Gs 116
a= Mean ±Standard Deviation , Ct: Cochlospermum tinctorium, Gs: Gardenia sokotensis, initial plant material:300g, Quinine: ED50= 16mg/kg 
 
 
 
 
Table 2 : Characteristics of fractions isolated from Dichloromethane extract of Cochlospermum tinctorium 
 
  TLC coloration Fractions    
 
Quantity (mg) State Spots
(RF) Visible  UV 366nm Liebermann Group
F1 730 (33.72%) Oily 0.89 yellow orange Absorbed blue  carotenoid 
0.89     
     
       
yellow orange Absorbed blue carotenoid
0.61 - Not absorbed violet  triterpene 
F2 1300 (60%) Oily 
0.11 - Not absorbed violet triterpene
F3 40(0.02%) Oily 0.11 - Not absorbed violet triterpene
Eluent: cyclohexane, toluen, ethyl acetate, acetic acid (2, 1, 2.5 ,0,1 v/v) 
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Table 3: Characteristics of fractions isolated from Dichloromethane-methanol(7/3v/v) extract of Gardenia sokotensis 
 
  TLC coloration     Quantity (mg) State Spots
(RF) Visible UV 366nm Diphenylborinate de sodium Liebermann Group 
0.98    Not absorbed  violet triterpene
0.83     
      
   
      
     
yellow Absorbed yellow  flavonoid
FGs1
 
602 (30%) oily 
0.94 yellow Absorbed
 
yellow
 
flavonoid
0.12 colourless violet
 
saponoside
0.66 Yellow Absorbed Yellow
 
flavonoid
FGs2 201 (10%) oily 
0.83 Yellow Absorbed flavonoid
Elution solvant: petroleum ether, toluen, ethyl acetate, acetic acid (5-2-2-1.5 v/v) 
 
 
 
                   Table 4: Activity of fractions (percentage reduction in parasitaemia) 
 
Plants Cochlospermum tinctorium (roots) Gardenia Sokotensis (leaves)  
Doses (mg/kg) 12.5 50 
Fractions FCt1 FCt2 FCt3 FGs1 Gs2
Mean % reduction 11±7.07a 13±4.95    11±7.78 20±3 42±10.50
a = Mean ±Standard Deviation 
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effective dose 50, dose required to inhibit growth of 50% of the parasites in mice was 
determined from following doses administrated (Cochlospermum tinctorium: 2.5, 7.5, 12.7, 
50, 150mg/kg; Gardenia sokotensis: 50, 100, 200, 300, 400, 500mg/kg). The chromatographic 
fractions isolated from the actives extracts were also tested on the parasites. 
 
Results and discussion 
 
Table I presents the percentage inhibition of extracts and the effective dose 50 (ED50) of the 
most active extracts. The applied doses of extracts showed a dose–dependent inhibition on the 
parasites. Fractions obtained from the two plants revealed mainly phenolic compounds 
(flavonoids) and terpenoids (triterpene, carotenoids and saponines).  
The dichloromethane extract of Cochlospermum tinctorium was the extract with the 
most antiplasmodial activity (ED50 =17.59 mg/kg), followed by the aqueous extract with an 
inhibition rate inferior to 50%% at 12.5mg/kg. The activity of aqueous extract although less 
active than the dichloromethane extract seems interesting according to the proposed 
thresholds for in vivo activity of antimalarial extracts (Rasoanaivo et al., 2004.) The 
fractionation of dichloromethane extract of the plant produced 3 main fractions labelled FCt1, 
FCt2, FCt3. The characteristics of the fractions are represented in Table II. The fractions FCt1 
and FCt3 seem pure. The antiplasmodial activity of fractions from the dichloromethane extract 
of Cochlospermum tinctorium did not show a significant antiplasmodial activity compared to 
that of the initial extract. Three hypotheses could explain this loss of activity of the 
dichloromethane extract during the fractionation process: firstly the result obtained could 
confirm the synergistic action among the chemical compounds in an extract and that has been 
demonstrated several times; secondly the decline of activity of fractions may be due to the 
denaturation of compounds during the storage. Indeed some secondary metabolites protect 
other metabolites (as antioxidants for example) and the break of this association can 
accelerate the degradation. Thirdly the active compound may be degraded by contact with 
silicagel. Indeed it has been demonstrated that the cochloxanthines (carotenoids) previously 
identified from the plant lose their inhibition against the Epstein Barr Virus when separated 
on silicagel (Diallo et al.,1999). The deactivation must be due to the cis–trans isomerisation, 
the trans form being practically inactive. Previous studies conducted with the plant have 
identified molecules with antiplasmodial activity (Ballin et al., 2002). Elsewhere, the crude 
aqueous extract has been found to have in vitro antiplasmodial activity (Benoit et al., 1995). 
According to our study, the plant extract was slightly toxic in vivo (LD50 = 230mg/kg) (Hodge 
and Sterner 1943,  Done,1980). The toxicity has been also indicated in vitro (Benoit et al., 
1999, Ballin et al., 2002). 
               Concerning the extracts of Gardenia sokotensis, the dichloromethane-methanol 
(7/3v/v) extract presented the highest percentage rate of parasite inhibition. (ED50 was around 
116mg /kg), and the aqueous extract showed the lowest inhibition rate. The fractionation of 
the dichloromethane–methanol (7/3v/v) extract gave two fractions, FGs1, FGs2 (Table III) and 
the fraction F2 was found to be active on the parasites (42% inhibition rate at 50 mg 
/kg)(Table IV). Neither fraction appeared pure but we did not succeed in isolating a pure 
fraction (Table III). The same difficulties have been met with a series of in vitro bioguided 
fractionation. In contrast with Cochlospermum tinctorium, the extracts of Gardenia sokotensis 
seem not to be toxic. (LD50>3000 mg/kg) (Hodge and Sterner 1943,  Done,1980) 
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Conclusion 
 
           This study has been a contribution to the assessment of possible antiplasmodial 
compounds from two plants from Burkina Faso. The total extract of Cochlospermum 
tinctorium demonstrated potent antiplasmodial activity but this activity decreased with the 
partitioning of the compounds. Indeed different fractions have been separated and some of 
them did not have antiplasmodial activity in vivo. Thus, crude extracts of Cochlospermum 
tinctorium were found to be more active than fractions and these results confirm those of 
previous studies carried out on the plant. Unlike the first plant, the screening of Gardenia 
sokotensis did not reach a pure fraction even if the antiplasmodial activity was promising. 
With regard to interpreting these results in relation to the traditional uses of the plants studied, 
great care should be taken since the aqueous extract (traditional form) of Gardenia sokotensis 
did not present antiplasmodial activity, but the traditional aqueous extract of C. tinctorium 
was active.  
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